UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Notice of Effectiveness

Effectiveness Date: September 30, 2022
Accession Number: 0001104659-22-104261
Submission Type: POS AM
CIK: 0001729214
Company Name: XORTX Therapeutics Inc.
File Number: 333-267328